Concert Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference.LEXINGTON, Mass. -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the Oppenheimer 19th Annual Healthcare Conference, being held at the Waldorf-Astoria Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Tuesday, November 4, 2008 at 8:20 a.m. (ET). About Concert Concert Pharmaceuticals, Inc. is a clinical stage biotechnology company dedicated to creating medically and commercially important new medicines through a novel approach utilizing the naturally-occurring element deuterium deuterium (d  tēr`ēəm), isotope of hydrogen with mass no. 2. The deuterium nucleus, called a deuteron, contains one proton and one neutron. . Concert applies its innovative platform to create
highly differentiated compounds based on well-understood biological
targets and drug molecules, yielding a rich pipeline of new chemical
entities (NCEs). By leveraging decades of pharmaceutical experience to
design NCEs from proven therapies, Concert's drug candidates have
potential for first-in-class use in under-served medical conditions See carpal tunnel syndrome, computer vision syndrome, dry eyes and deep vein thrombosis. , as
well as best-in-class efficacy and safety, while reducing R&D risk,
time, and expense. The Company has over 100 patent applications for new
drug candidates addressing a broad range of therapeutic areas, including
vasomotor vasomotor /vaso·mo·tor/ (-mo´tor)1. affecting the caliber of blood vessels. 2. a vasomotor agent or nerve. va·so·mo·tor adj. symptoms, HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and fibrotic diseases, among others. Since its inception in 2006, Concert has raised more than $96 million and has been financed by leading venture capitalists Venture Capitalist An investor who provides capital to either start-up ventures or support small companies who wish to expand but do not have access to public funding. Notes: Venture capitalists usually expect higher returns for the additional risks taken. and institutional investors. A listing of Concert's institutional shareholders and additional corporate information is available online at http://www.concertpharma.com. CoNCERT and CoNCERT Pharmaceuticals are trademarks of Concert Pharmaceuticals, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion